Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article
Open Access

ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance

DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS and VASILIKI BRAVOU
Cancer Genomics & Proteomics March 2018, 15 (2) 127-141;
DIMITRIOS TSOUMAS
1Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOFIA NIKOU
1Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EFSTATHIA GIANNOPOULOU
2Clinical Oncology Laboratory, University of Patras Medical School, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SPYRIDON CHAMPERIS TSANIRAS
3Department of Physiology, Medical School, University of Patras, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAIDO SIRINIAN
2Clinical Oncology Laboratory, University of Patras Medical School, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS MAROULIS
4Department of Surgery, University of Patras Medical School, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STAVROS TARAVIRAS
3Department of Physiology, Medical School, University of Patras, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VASSILIKI ZOLOTA
5Department of Pathology, University of Patras Medical School, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARALABOS P. KALOFONOS
2Clinical Oncology Laboratory, University of Patras Medical School, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VASILIKI BRAVOU
1Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vibra{at}upatras.gr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 15 no. 2 127-141
PMID 
29496692

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received December 28, 2017
  • Revision received January 24, 2018
  • Accepted February 2, 2018
  • Published online March 1, 2018.

Copyright & License 
Copyright © 2018 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. DIMITRIOS TSOUMAS1,*,
  2. SOFIA NIKOU1,*,
  3. EFSTATHIA GIANNOPOULOU2,
  4. SPYRIDON CHAMPERIS TSANIRAS3,
  5. CHAIDO SIRINIAN2,
  6. IOANNIS MAROULIS4,
  7. STAVROS TARAVIRAS3,
  8. VASSILIKI ZOLOTA5,
  9. HARALABOS P. KALOFONOS2 and
  10. VASILIKI BRAVOU1⇑
  1. 1Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras, Greece
  2. 2Clinical Oncology Laboratory, University of Patras Medical School, Patras, Greece
  3. 3Department of Physiology, Medical School, University of Patras, Patras, Greece
  4. 4Department of Surgery, University of Patras Medical School, Patras, Greece
  5. 5Department of Pathology, University of Patras Medical School, Patras, Greece
  1. Correspondence to: Vasiliki Bravou, MD, Ph.D., Pathologist, Assistant Professor, Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras 26500, Greece. Tel: +30 2610969194-5, e-mail: vibra{at}upatras.gr
View Full Text

Statistics from Altmetric.com

Cited By...

  • 74 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics & Proteomics
Vol. 15, Issue 2
March-April 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS, VASILIKI BRAVOU
Cancer Genomics & Proteomics Mar 2018, 15 (2) 127-141;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS, VASILIKI BRAVOU
Cancer Genomics & Proteomics Mar 2018, 15 (2) 127-141;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Casein Kinase 2{alpha} Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression
  • Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
  • Casein Kinase 2{alpha} Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress
  • Google Scholar

Keywords

  • ILK
  • EMT
  • chemotherapy
  • chemoresistance
  • Colorectal cancer
  • cancer stem cells
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire